معرفی
Jess Kerr Gaffney is a Researcher in Psychological Medicine, focusing on mental health research with a strong emphasis on treatment-resistant depression, autism spectrum disorder, and eating disorders. Her work integrates meta-analyses, randomized controlled trials, and neuroimaging studies to advance understanding of comorbid conditions and therapeutic interventions.
Key research interests include the intersection of autism and eating disorders, neuroanatomical correlates of psychiatric conditions, and the clinical efficacy of pharmacological treatments. She has led projects such as 'Experiences, motivations, and risks associated with substance use in autism spectrum disorder' (Primary Investigator) and contributed to the LQD trial evaluating lithium vs. quetiapine in depression.
Her publications span over 34 peer-reviewed articles, including high-impact studies in The Lancet Psychiatry and Psychological Medicine. She collaborates widely, contributing to systematic reviews and ethical frameworks for co-produced research involving neurodiverse populations.
Jess has secured grants from the EC European Commission and the Psychiatry Research Trust, demonstrating her role in advancing translational mental health research. Her work aligns with UN Sustainable Development Goals related to good health and well-being (SDG 3).
